ACNB vs BIO · P/E 11, rev $103.0M vs rev $651.0M
ACNB Corporation (ACNB) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
ACNB Corporation (ACNB) is a banks - regional company listed on NASDAQ.
BIO (BIO) common stock.
Latest reported ACNB revenue for 2026-06-30 was $103.0M. Net income was $28.9M. ACNB currently screens at market cap $573.6M and trailing P/E 11.3.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
ACNB currently screens at market cap $573.6M and trailing P/E 11.3. BIO currently screens at market cap $0.
Not investment advice. Open the ACNB and BIO stock pages for the full models.
Not investment advice.